457 related articles for article (PubMed ID: 10607834)
21. Two novel mutations affecting mRNA splicing of the neurofibromatosis type 1 (NF1) gene.
Perrin G; Morris MA; Antonarakis SE; Boltshauser E; Hutter P
Hum Mutat; 1996; 7(2):172-5. PubMed ID: 8829638
[No Abstract] [Full Text] [Related]
22. Recent advances in neurofibromatosis type 1.
Arun D; Gutmann DH
Curr Opin Neurol; 2004 Apr; 17(2):101-5. PubMed ID: 15021234
[TBL] [Abstract][Full Text] [Related]
23. Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain.
Fahsold R; Hoffmeyer S; Mischung C; Gille C; Ehlers C; Kücükceylan N; Abdel-Nour M; Gewies A; Peters H; Kaufmann D; Buske A; Tinschert S; Nürnberg P
Am J Hum Genet; 2000 Mar; 66(3):790-818. PubMed ID: 10712197
[TBL] [Abstract][Full Text] [Related]
24. Clustering of mutations in the 5' tertile of the NF1 gene in Slovakia patients with optic pathway glioma.
Bolcekova A; Nemethova M; Zatkova A; Hlinkova K; Pozgayova S; Hlavata A; Kadasi L; Durovcikova D; Gerinec A; Husakova K; Pavlovicova Z; Holobrada M; Kovacs L; Ilencikova D
Neoplasma; 2013; 60(6):655-65. PubMed ID: 23906300
[TBL] [Abstract][Full Text] [Related]
25. The spectrum of NF1 mutations in Korean patients with neurofibromatosis type 1.
Jeong SY; Park SJ; Kim HJ
J Korean Med Sci; 2006 Feb; 21(1):107-12. PubMed ID: 16479075
[TBL] [Abstract][Full Text] [Related]
26. Thirty-nine novel neurofibromatosis 1 (NF1) gene mutations identified in Slovak patients.
Nemethova M; Bolcekova A; Ilencikova D; Durovcikova D; Hlinkova K; Hlavata A; Kovacs L; Kadasi L; Zatkova A
Ann Hum Genet; 2013 Sep; 77(5):364-79. PubMed ID: 23758643
[TBL] [Abstract][Full Text] [Related]
27. [Analysis of NF1 gene mutations among eleven sporadic patients with neurofibromatosis type 1].
Peng C; Ma S; Tang X; Yang J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Aug; 35(4):480-483. PubMed ID: 30098238
[TBL] [Abstract][Full Text] [Related]
28. Recurrent NF1 gene mutation in a patient with oligosymptomatic neurofibromatosis type 1 (NF1).
Buske A; Gewies A; Lehmann R; Rüther K; Algermissen B; Nürnberg P; Tinschert S
Am J Med Genet; 1999 Oct; 86(4):328-30. PubMed ID: 10494088
[TBL] [Abstract][Full Text] [Related]
29. Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome.
Messiaen L; Yao S; Brems H; Callens T; Sathienkijkanchai A; Denayer E; Spencer E; Arn P; Babovic-Vuksanovic D; Bay C; Bobele G; Cohen BH; Escobar L; Eunpu D; Grebe T; Greenstein R; Hachen R; Irons M; Kronn D; Lemire E; Leppig K; Lim C; McDonald M; Narayanan V; Pearn A; Pedersen R; Powell B; Shapiro LR; Skidmore D; Tegay D; Thiese H; Zackai EH; Vijzelaar R; Taniguchi K; Ayada T; Okamoto F; Yoshimura A; Parret A; Korf B; Legius E
JAMA; 2009 Nov; 302(19):2111-8. PubMed ID: 19920235
[TBL] [Abstract][Full Text] [Related]
30. Recurrence of a nonsense mutation in the NF1 gene causing classical neurofibromatosis type 1.
Estivill X; Lázaro C; Casals T; Ravella A
Hum Genet; 1991 Dec; 88(2):185-8. PubMed ID: 1757093
[TBL] [Abstract][Full Text] [Related]
31. NF1 mutation analysis using a combined heteroduplex/SSCP approach.
Abernathy CR; Rasmussen SA; Stalker HJ; Zori R; Driscoll DJ; Williams CA; Kousseff BG; Wallace MR
Hum Mutat; 1997; 9(6):548-54. PubMed ID: 9195229
[TBL] [Abstract][Full Text] [Related]
32. Clinical characteristics and mutation Spectrum of NF1 in 12 Chinese families with orbital/periorbital plexiform Neurofibromatosis type 1.
Chai P; Luo Y; Zhou C; Wang Y; Fan X; Jia R
BMC Med Genet; 2019 Sep; 20(1):158. PubMed ID: 31533651
[TBL] [Abstract][Full Text] [Related]
33. Disruption of exonic splicing enhancer elements is the principal cause of exon skipping associated with seven nonsense or missense alleles of NF1.
Zatkova A; Messiaen L; Vandenbroucke I; Wieser R; Fonatsch C; Krainer AR; Wimmer K
Hum Mutat; 2004 Dec; 24(6):491-501. PubMed ID: 15523642
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of Molecular and Clinical Findings in Children With Neurofibromatosis Type 1: Identification of 15 Novel Variants.
Bildirici Y; Kocaaga A; Karademir-Arslan CN; Yimenicioglu S
Pediatr Neurol; 2023 Dec; 149():69-74. PubMed ID: 37806041
[TBL] [Abstract][Full Text] [Related]
35. A novel diagnostic method to detect truncated neurofibromin in neurofibromatosis 1.
Esposito T; Piluso G; Saracino D; Uccello R; Schettino C; Dato C; Capaldo G; Giugliano T; Varriale B; Paolisso G; Di Iorio G; Melone MA
J Neurochem; 2015 Dec; 135(6):1123-8. PubMed ID: 26478990
[TBL] [Abstract][Full Text] [Related]
36. NF1 gene mutations in Japanese with neurofibromatosis 1 (NF1).
Hatta N; Horiuchi T; Watanabe I; Kobayashi Y; Shirakata Y; Ohtsuka H; Minami T; Ueda K; Kokoroishi T; Fujita S
Biochem Biophys Res Commun; 1995 Jul; 212(2):697-704. PubMed ID: 7542886
[TBL] [Abstract][Full Text] [Related]
37. Prenatal diagnosis of sporadic neurofibromatosis type 1 (NF1) by RNA and DNA analysis of a splicing mutation.
Ars E; Kruyer H; Gaona A; Serra E; Lázaro C; Estivill X
Prenat Diagn; 1999 Aug; 19(8):739-42. PubMed ID: 10451518
[TBL] [Abstract][Full Text] [Related]
38. Mutation spectrum of NF1 and clinical characteristics in 78 Korean patients with neurofibromatosis type 1.
Ko JM; Sohn YB; Jeong SY; Kim HJ; Messiaen LM
Pediatr Neurol; 2013 Jun; 48(6):447-53. PubMed ID: 23668869
[TBL] [Abstract][Full Text] [Related]
39. NF1 gene analysis based on DHPLC.
De Luca A; Buccino A; Gianni D; Mangino M; Giustini S; Richetta A; Divona L; Calvieri S; Mingarelli R; Dallapiccola B
Hum Mutat; 2003 Feb; 21(2):171-2. PubMed ID: 12552569
[TBL] [Abstract][Full Text] [Related]
40. No correlation between NF1 mutation position and risk of optic pathway glioma in 77 unrelated NF1 patients.
Hutter S; Piro RM; Waszak SM; Kehrer-Sawatzki H; Friedrich RE; Lassaletta A; Witt O; Korbel JO; Lichter P; Schuhmann MU; Pfister SM; Tabori U; Mautner VF; Jones DTW
Hum Genet; 2016 May; 135(5):469-475. PubMed ID: 26969325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
